These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 31387604)

  • 21. Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer: IL-2 promotes development of anti-tumor memory T cells in vivo.
    Hughes DP; Baskar D; Urban FF; Friedman MS; Braun TM; McDonagh KT
    Cytotherapy; 2005; 7(5):396-407. PubMed ID: 16236629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
    Matsumura T; Sussman JJ; Krinock RA; Chang AE; Shu S
    Cancer Res; 1994 May; 54(10):2744-50. PubMed ID: 8168105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of tolerogenic dendritic cells in the tumor draining lymph nodes by CD8+ T cells engineered to express CD40 ligand.
    Higham EM; Wittrup KD; Chen J
    J Immunol; 2010 Apr; 184(7):3394-400. PubMed ID: 20200275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
    Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
    Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NR4A transcription factors limit CAR T cell function in solid tumours.
    Chen J; López-Moyado IF; Seo H; Lio CJ; Hempleman LJ; Sekiya T; Yoshimura A; Scott-Browne JP; Rao A
    Nature; 2019 Mar; 567(7749):530-534. PubMed ID: 30814732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of β-Adrenergic Receptors Improves CD8
    Daher C; Vimeux L; Stoeva R; Peranzoni E; Bismuth G; Wieduwild E; Lucas B; Donnadieu E; Bercovici N; Trautmann A; Feuillet V
    Cancer Immunol Res; 2019 Nov; 7(11):1849-1863. PubMed ID: 31527069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human effector CD8
    Mietz J; Kaulfuss M; Egli L; Opitz L; Münz C; Chijioke O
    EBioMedicine; 2024 Aug; 106():105240. PubMed ID: 38986249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor.
    Kjaergaard J; Peng L; Cohen PA; Drazba JA; Weinberg AD; Shu S
    J Immunol; 2001 Dec; 167(11):6669-77. PubMed ID: 11714839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
    Hu HM; Winter H; Urba WJ; Fox BA
    J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.
    Plautz GE; Touhalisky JE; Shu S
    Cell Immunol; 1997 Jun; 178(2):101-7. PubMed ID: 9225000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.
    Paulos CM; Wrzesinski C; Kaiser A; Hinrichs CS; Chieppa M; Cassard L; Palmer DC; Boni A; Muranski P; Yu Z; Gattinoni L; Antony PA; Rosenberg SA; Restifo NP
    J Clin Invest; 2007 Aug; 117(8):2197-204. PubMed ID: 17657310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation and synergistic antitumor response.
    Wang LX; Shu S; Disis ML; Plautz GE
    Blood; 2007 Jun; 109(11):4865-76. PubMed ID: 17284532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.
    Hiura T; Kagamu H; Miura S; Ishida A; Tanaka H; Tanaka J; Gejyo F; Yoshizawa H
    J Immunol; 2005 Oct; 175(8):5058-66. PubMed ID: 16210609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment-enhanced CD4+Foxp3+ glucocorticoid-induced TNF receptor family related high regulatory tumor-infiltrating T cells limit the effectiveness of cytokine-based immunotherapy.
    Berhanu A; Huang J; Watkins SC; Okada H; Storkus WJ
    J Immunol; 2007 Mar; 178(6):3400-8. PubMed ID: 17339434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD8-mediated type 1 antitumor responses selectively modulate endogenous differentiated and nondifferentiated T cell localization, activation, and function in progressive breast cancer.
    Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA
    J Immunol; 2006 Dec; 177(11):8191-201. PubMed ID: 17114496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoid-induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen-specific CD8+ T cells with tumor regression.
    Imai N; Ikeda H; Tawara I; Wang L; Wang L; Nishikawa H; Kato T; Shiku H
    Cancer Sci; 2009 Jul; 100(7):1317-25. PubMed ID: 19432889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
    Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
    J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
    Zhang X; Niedermann G
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PGE
    Lacher SB; Dörr J; de Almeida GP; Hönninger J; Bayerl F; Hirschberger A; Pedde AM; Meiser P; Ramsauer L; Rudolph TJ; Spranger N; Morotti M; Grimm AJ; Jarosch S; Oner A; Gregor L; Lesch S; Michaelides S; Fertig L; Briukhovetska D; Majed L; Stock S; Busch DH; Buchholz VR; Knolle PA; Zehn D; Dangaj Laniti D; Kobold S; Böttcher JP
    Nature; 2024 May; 629(8011):417-425. PubMed ID: 38658748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.